APA

Suez D., Kriván G., Jolles S., Stein M., Gupta S., Paris K., van Hagen P. M., Brodszki N., Engl W., Leibl H., McCoy B. & Yel L. (20200525). Safety and tolerability of subcutaneous immunoglobulin 20% in primary immunodeficiency diseases from two continents. : Immunotherapy.

Chicago

Suez Daniel, Kriván Gergely, Jolles Stephen, Stein Mark, Gupta Sudhir, Paris Kenneth, van Hagen P Martin, Brodszki Nicholas, Engl Werner, Leibl Heinz, McCoy Barbara and Yel Leman. 20200525. Safety and tolerability of subcutaneous immunoglobulin 20% in primary immunodeficiency diseases from two continents. : Immunotherapy.

Harvard

Suez D., Kriván G., Jolles S., Stein M., Gupta S., Paris K., van Hagen P. M., Brodszki N., Engl W., Leibl H., McCoy B. and Yel L. (20200525). Safety and tolerability of subcutaneous immunoglobulin 20% in primary immunodeficiency diseases from two continents. : Immunotherapy.

MLA

Suez Daniel, Kriván Gergely, Jolles Stephen, Stein Mark, Gupta Sudhir, Paris Kenneth, van Hagen P Martin, Brodszki Nicholas, Engl Werner, Leibl Heinz, McCoy Barbara and Yel Leman. Safety and tolerability of subcutaneous immunoglobulin 20% in primary immunodeficiency diseases from two continents. : Immunotherapy. 20200525.